NCT00241163View on ClinicalTrials.gov

TachoComb S Versus Standard Surgical Treatment in Surgical Resection of Renal Tumour (TC-015-IN)

PHASE3CompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

Not specified

Conditions
Surgical Resection of Superficial Renal Tumour
Interventions
PROCEDURE

Fibrinogen (human) + thrombin (human) (TachoSil)

Trial Locations (1)

Unknown

Roskilde

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT00241163 - TachoComb S Versus Standard Surgical Treatment in Surgical Resection of Renal Tumour (TC-015-IN) | Biotech Hunter | Biotech Hunter